Glycolipid antigens and autoantibodies in autoimmune neuropathies

Willison, H.J. and Goodyear, C.S. (2013) Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends in Immunology, 34(9), pp. 453-459. (doi:10.1016/j.it.2013.05.001)

Full text not currently available from Enlighten.

Abstract

Autoantibodies to glycans present on glycolipids mediate the postinfectious paralytic disease, Guillain–Barré syndrome (GBS). These glycans are also found on lipo-oligosaccharides (LOSs) of GBS-inducing microbes, suggesting molecular mimicry as a mechanism for disease induction. How B lymphocyte tolerance to self-glycans is regulated during the initiation phase of the disease is currently under investigation. The discovery of antiglycolipid antibodies that bind to heteromeric glycolipid complexes has generated new insights in this field. Heteromeric complexes are structurally distinct glycolipids that interact to form new molecular shapes capable of either enhancing or attenuating recognition by autoantibodies. Although the principles emerging from this phenomenon have a substantial impact on diagnostics methods, they also raise intriguing questions about the diversity of innate antibody repertoires, mechanisms of tolerance, and autoantibody targeting of neural membranes.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Willison, Professor Hugh and Goodyear, Professor Carl
Authors: Willison, H.J., and Goodyear, C.S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Trends in Immunology
ISSN:1471-4906
ISSN (Online):1471-4981

University Staff: Request a correction | Enlighten Editors: Update this record